↓ Skip to main content

Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases

Overview of attention for article published in BMC Musculoskeletal Disorders, December 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases
Published in
BMC Musculoskeletal Disorders, December 2015
DOI 10.1186/s12891-015-0843-4
Pubmed ID
Authors

Elia Valls Pascual, Lucía Martínez-Costa, Fernando Santander

Abstract

Central serous chorioretinopathy is a disorder often related to systemic corticosteroids, drugs commonly used in rheumatologists' clinical practice. Central serous chorioretinopathy prognosis is generally good but in some cases, it may lead to substantial loss of vision resulting in an important functional limitation for patients. It is very important to distinguish this pathology from other diseases involving retinal detachment. When central serous chorioretinopathy and uveitis coexist, it is mandatory to distinguish serous retinal detachment from a uveitis worsening, as the respective treatments can be radically different. We describe three cases of central serous chorioretinopathy in patients taking systemic corticosteroids due to rheumatological diseases (ankylosing spondylitis, systemic lupus erythematosus and Behçet's disease). They were diagnosed and managed at our Multidisciplinary (Rheumatology-Ophthalmology) Uveitis Clinic. All three cases improved after corticosteroids dose tapering. Central serous chorioretinopathy must be kept in mind by rheumatologists as it is related to systemic corticosteroids.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 14%
Lecturer 2 10%
Researcher 2 10%
Student > Postgraduate 2 10%
Student > Bachelor 1 5%
Other 3 14%
Unknown 8 38%
Readers by discipline Count As %
Medicine and Dentistry 10 48%
Nursing and Health Professions 1 5%
Psychology 1 5%
Agricultural and Biological Sciences 1 5%
Unknown 8 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2017.
All research outputs
#13,376,550
of 22,834,308 outputs
Outputs from BMC Musculoskeletal Disorders
#1,891
of 4,045 outputs
Outputs of similar age
#185,340
of 387,671 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#39
of 70 outputs
Altmetric has tracked 22,834,308 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,045 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,671 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.